- Trials with a EudraCT protocol (26)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
26 result(s) found for: Disodium phosphate.
Displaying page 1 of 2.
EudraCT Number: 2017-000658-20 | Sponsor Protocol Number: 7621 | Start Date*: 2017-04-24 |
Sponsor Name: | ||
Full Title: Combinated systemic and intratympanic steroid therapy in idiopathic sudden sensorineural hearing loss | ||
Medical condition: Idiopathic Sudden Sensorineural Hearing Loss | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002298-20 | Sponsor Protocol Number: CHD046-17 | Start Date*: 2018-01-23 | |||||||||||
Sponsor Name:Centre Hospitalier Départemental Vendée | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004890-21 | Sponsor Protocol Number: NL72427.068.19 | Start Date*: 2021-01-18 |
Sponsor Name:Academic Hospital Maastricht (azM) | ||
Full Title: Effectiveness of Periocular drug Injection in CATaract surgery | ||
Medical condition: cystoid macular edema (CME) | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) DE (Prematurely Ended) AT (Prematurely Ended) PT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2018-003001-26 | Sponsor Protocol Number: 1234 | Start Date*: 2018-12-05 |
Sponsor Name:Medizinische Universität Innsbruck, Universitätsklinik für Anästhesie und Allgemeine Intensivmedizin | ||
Full Title: Ropivacain 0,2% plus Dexamethason versus Ropivacain 0,2% plus Placebo in modified pectoral block - A randomized, double-blind, prospective trial | ||
Medical condition: women scheduled for elective breast surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-004873-14 | Sponsor Protocol Number: NL_42463.068.12 | Start Date*: 2013-03-27 |
Sponsor Name:University Eye Clinic Maastricht | ||
Full Title: PREvention of Macular EDema after cataract surgery | ||
Medical condition: Cystoid Macular Edema (CME) after cataract surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) HU (Completed) PT (Completed) DE (Completed) ES (Completed) BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000915-53 | Sponsor Protocol Number: DEXAPAE | Start Date*: 2020-10-08 | |||||||||||
Sponsor Name:Department of Radiology, Rigshospitalet, Denmark | |||||||||||||
Full Title: Randomized double-blind placebo-controlled trial on the efficiency of a single dose dexamethasone in reducing the postembolization syndrome in men undergoing prostatic artery embolization for benig... | |||||||||||||
Medical condition: Benign prostatic hyperplasia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001179-36 | Sponsor Protocol Number: C-04-72 | Start Date*: 2005-08-23 |
Sponsor Name:Alcon Pharma GmbH | ||
Full Title: Efficacy and safety of Dexa-Polyspectran® drops, preserved with benzalkonium chloride, vs. Dexa-Polyspectran® drops without dexamethasone phosphate, preserved with benzalkonium chloride, in patient... | ||
Medical condition: acute bacterial otitis externa | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-003825-24 | Sponsor Protocol Number: 2059/2022 | Start Date*: 2024-03-15 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Drug Concentration and degradation profiles of steroid and antibiotic eye drops in human aqueous humor. | ||
Medical condition: Postoperative inflammatory response - pharmakokinetics of steroids and antibiotics applied as eye drops | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002585-32 | Sponsor Protocol Number: Mpp01 | Start Date*: 2017-11-15 |
Sponsor Name:Infektionskliniken Danderyds sjukhus AB | ||
Full Title: A randomised, multicentre, controlled trial to study the duration of supplemental oxygen treatment in adults with Mycoplasma pneumoniae pneumonia treated with betamethasone in addition to antibiotics | ||
Medical condition: Mycoplasma pneumoniae pneumonia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001725-75 | Sponsor Protocol Number: 2015-DFU-301 | Start Date*: 2018-12-12 |
Sponsor Name:FirstString Research, Inc. | ||
Full Title: A Phase 3, Randomized, Double-blind, Parallel-group, Vehicle controlled, Multicenter Study of the Efficacy and Safety of Granexin Gel in the Treatment of Diabetic Foot Ulcer (GAIT 1) | ||
Medical condition: Diabetic Foot Ulcer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000620-17 | Sponsor Protocol Number: DRKS00005503 | Start Date*: 2014-04-28 |
Sponsor Name:Landeshauptstadt Stuttgart, represented by the Executive Medical Director Klinikum Stuttgart | ||
Full Title: High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS lymphoma - randomized phase III trial | ||
Medical condition: Primary CNS lymphoma (PCNSL) accounts for 1 to 2% of all Non-Hodgkin's lymphomas (NHL) and for 2 to 7% of all primary CNS tumors. It's incidence has increased over the past 30 years, particularly i... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) DK (Completed) NO (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-001221-98 | Sponsor Protocol Number: 1.3 | Start Date*: 2018-06-25 |
Sponsor Name:Medical University of Vienna, Department of Clinical Pharmacology | ||
Full Title: DEXAMETHASONE AS ADJUVANT FOR PERIPHERAL NERVE BLOCKADE: A RANDOMIZED, TRIPLE-BLINDED AND CROSSOVER STUDY IN VOLUNTEERS | ||
Medical condition: The combination of local anaesthetics plus dexamethasone shall increase the duration of regional anaesthetic blocks. It is a volunteers´study. Three different block combination are performed. One b... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-001958-10 | Sponsor Protocol Number: MD2018 | Start Date*: 2018-10-25 |
Sponsor Name:Abteilung für Hals-, Nasen- und Ohrenkrankheiten MUW, AKH Wien | ||
Full Title: Dexamethasone 21-dihydrogenphosphat and Triamcinolone acetonide in the treatment of Menière´s disease: a randomized, multicentric efficacy trial | ||
Medical condition: In our study we try to evaluate the effect of intratympanic Triamcinolon acetonide and Dexamethason 21-dihydrohenphosphat on vertigo control calculation, Hydrops MRI, vHIT (video head impuls test),... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2020-001750-22 | Sponsor Protocol Number: 20HH5926 | Start Date*: 2020-07-09 |
Sponsor Name:Joint Research Compliance Office | ||
Full Title: MATIS: Phase 2/3, Randomised, Open-Label, Single-Site, Multi-Arm Trial of Ruxolitinib Plus Best Supportive Treatment (BST) versus Fostamatinib Plus BST versus BST for COVID-19 pneumonia | ||
Medical condition: COVID-19 pneumonia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000873-56 | Sponsor Protocol Number: CARPA2013 | Start Date*: 2013-07-04 | |||||||||||
Sponsor Name:Federico Diaz González | |||||||||||||
Full Title: Randomized, two paralel groups, open clinical trial stratified by severity to stimate the cost-effectivity of surgical vs corticosteroid injection treatment on carpal tunnel syndrome | |||||||||||||
Medical condition: Carpal tunnel syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002052-14 | Sponsor Protocol Number: EURO-HIT-HLH | Start Date*: 2011-06-07 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA MEYER | |||||||||||||
Full Title: EURO-HIT-HLH European cooperative pilot study for testing Hybrid ImmunoTherapy for Hemophagocytic LymphoHistiocytosis | |||||||||||||
Medical condition: Familial hemophagoytic lymphohistiocytosis | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) DE (Completed) AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000492-32 | Sponsor Protocol Number: AMIII | Start Date*: 2019-01-14 |
Sponsor Name:Charité-Universitätsmedizin Berlin | ||
Full Title: Effects of antibiotics on micobiota, pulmonary immune response and incidence of ventilator-associated infections | ||
Medical condition: mechanically ventilated patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2018-000497-30 | Sponsor Protocol Number: FIS-VED-2017-01 | Start Date*: 2018-05-28 | |||||||||||
Sponsor Name:Fundación Pública Andaluza para la Gestión en Salud de Sevilla (FISEVI) | |||||||||||||
Full Title: Phase II clinical trial to evaluate the safety and efficacy of Vedolizumab combined with antiretroviral treatment to achieve functional healing in people infected with HIV-1 without previous antire... | |||||||||||||
Medical condition: Adult patients infected with HIV and without previous antiretroviral treatment. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000732-54 | Sponsor Protocol Number: NCH-201803 | Start Date*: 2021-10-11 | |||||||||||
Sponsor Name:Rheinische Friedrich-Wilhelms-Universität Bonn | |||||||||||||
Full Title: FINISHER - Fight Inflammation to Improve outcome after aneurysmal Subarachnoid Hemorrhage | |||||||||||||
Medical condition: aneurysmal subarachnoid hemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002844-25 | Sponsor Protocol Number: SM1-JOAST-2019 | Start Date*: 2019-11-26 | ||||||||||||||||
Sponsor Name:Daniel Hägi-Pedersen | ||||||||||||||||||
Full Title: Effect of Combinations of Paracetamol, Ibuprofen, and Dexamethasone on Patient-Controlled Morphine Consumption in the First 24 Hours After Total Hip Arthroplasty. The RECIPE Randomized Clinical Trial | ||||||||||||||||||
Medical condition: Acute postoperative pain after hip arthroplasty | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
